相似文献
1
DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer.
Nat Rev Clin Oncol. 2010 Mar;7(3):174-7. doi: 10.1038/nrclinonc.2009.235.
2
A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
Clin Colorectal Cancer. 2013 Jun;12(2):128-35. doi: 10.1016/j.clcc.2012.11.003. Epub 2012 Dec 29.
3
Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
Clin Cancer Res. 2011 Dec 1;17(23):7470-8. doi: 10.1158/1078-0432.CCR-11-1048. Epub 2011 Oct 13.
4
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
Oncologist. 2016 May;21(5):618-25. doi: 10.1634/theoncologist.2015-0530. Epub 2016 Mar 23.
5
[Correlations between DNA mismatch repair (MMR) and prognosis and prediction of treatment efficacy in stage II/II colon cancer].
Zhonghua Zhong Liu Za Zhi. 2014 Nov;36(11):844-8.
6
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24.
7
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67. doi: 10.1007/s00280-009-1206-3. Epub 2009 Dec 24.
8
Prognostic and predictive roles of DNA mismatch repair status in colon cancer patients treated with oxaliplatin-based chemotherapy: a retrospective study.
J Physiol Pharmacol. 2020 Aug;71(4). doi: 10.26402/jpp.2020.4.12. Epub 2020 Dec 12.
9
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
J Clin Oncol. 2015 Dec 10;33(35):4176-87. doi: 10.1200/JCO.2015.63.4238. Epub 2015 Nov 2.
10
Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S630-7. doi: 10.1245/s10434-015-4807-6. Epub 2015 Aug 14.
引用本文的文献
1
The influence of the microbiome on radiotherapy and DNA damage responses.
Front Oncol. 2025 Mar 17;15:1552750. doi: 10.3389/fonc.2025.1552750. eCollection 2025.
2
Mismatch repair deficiency confers worse survival in stage IV colon cancer.
J Gastrointest Oncol. 2024 Dec 31;15(6):2521-2532. doi: 10.21037/jgo-24-387. Epub 2024 Dec 28.
3
Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies.
Cancer Manag Res. 2024 Oct 10;16:1389-1403. doi: 10.2147/CMAR.S481656. eCollection 2024.
4
The Relationship Between DNA Mismatch Repair Status and Clinicopathologic Characteristics in Colon Cancer.
Turk J Gastroenterol. 2024 Aug 12;35(9):718-725. doi: 10.5152/tjg.2024.23366.
5
Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns.
Diagnostics (Basel). 2024 May 22;14(11):1076. doi: 10.3390/diagnostics14111076.
6
CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.
Mol Cancer. 2024 Mar 21;23(1):59. doi: 10.1186/s12943-024-01971-7.
7
Methylated BCAT1/IKZF1 DNA: a breakthrough in colorectal cancer diagnosis?
Ann Med Surg (Lond). 2023 Nov 7;86(1):11-12. doi: 10.1097/MS9.0000000000001495. eCollection 2024 Jan.
8
Personalizing adjuvant therapy for patients with colorectal cancer.
Nat Rev Clin Oncol. 2024 Jan;21(1):67-79. doi: 10.1038/s41571-023-00834-2. Epub 2023 Nov 24.
9
Anxiety is Associated With Geriatric Assessment Impairments and Reduced Quality of Life Among Older Adults With Colorectal Cancer: Results From the CARE Registry.
Clin Colorectal Cancer. 2023 Dec;22(4):383-389. doi: 10.1016/j.clcc.2023.08.001. Epub 2023 Aug 5.
10
Broad spectrum integrin inhibitor GLPG-0187 bypasses immune evasion in colorectal cancer by TGF-β signaling mediated downregulation of PD-L1.
Am J Cancer Res. 2023 Jul 15;13(7):2938-2947. eCollection 2023.
本文引用的文献
1
Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.
Cancer. 2010 Apr 1;116(7):1691-8. doi: 10.1002/cncr.24913.
2
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
J Clin Oncol. 2009 Apr 10;27(11):1814-21. doi: 10.1200/JCO.2008.18.2071. Epub 2009 Mar 9.
3
Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3208-15. doi: 10.1158/1055-9965.EPI-08-0512.
4
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21.
5
Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer.
Br J Surg. 2008 Jul;95(7):868-75. doi: 10.1002/bjs.6172.
6
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.
7
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
J Clin Oncol. 2007 Aug 10;25(23):3456-61. doi: 10.1200/JCO.2007.11.2144.
8
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
J Clin Oncol. 2007 Mar 1;25(7):767-72. doi: 10.1200/JCO.2006.05.8172. Epub 2007 Jan 16.
9
Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Gastroenterology. 2006 Sep;131(3):729-37. doi: 10.1053/j.gastro.2006.06.005.
10
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
Int J Colorectal Dis. 2007 Feb;22(2):145-52. doi: 10.1007/s00384-006-0131-8. Epub 2006 May 25.
Zotero 插件